Why Is Nautilus Biotechnolgy, Inc. (NAUT) Up 25% Today?
Biotech's biggest mover today
Nautilus Biotechnolgy, Inc. is the biggest Biotech gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
The move
NAUT trades at $3.24, up +24.6% on the session, with a market capitalisation of $412.3 million.
Volume is 3.2 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.
Against its 52-week range of $0.84 to $4.31, today's price sits 69% of the way up it.
No company news on file
There is no company filing, analyst action or insider transaction on our record to explain today's move.
For context, Biotech names are up an average of -1.8% today, so some of this is the sector rather than the company.
A move without a disclosed cause is common and not sinister. It is simply a move we cannot explain, and saying so is more useful than guessing.
| Metric | Value | Context |
|---|---|---|
| Change today | +24.6% | Biotech average -1.8% |
| Volume | 13,485,716 | 3.2x the 30-day average |
| Market cap | $412.3 million | Biotechnology |
| Range | $0.84 – $4.31 | 52 weeks |
| Metric | Value | Context |
|---|---|---|
| Change today | +24.6% | Biotech average -1.8% |
| Volume | 13,485,716 | 3.2x the 30-day average |
| Market cap | $412.3 million | Biotechnology |
| Range | $0.84 – $4.31 | 52 weeks |
The bottom line
A large move with no disclosed cause. That is worth knowing, and it is not a reason to act. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.